TabletsTablets
Schedule H (Prescription Required)Antidepressants & Mood StabilizersCode: 1124

Fluvoxamine Maleate Tablets 100mg

Generic Formulation:Fluvoxamine Maleate Tablets IP 100mg
Pack Size:10's
Common Commercial Brand Equivalents:Market reference only
Jan Aushadhi MRP
₹69.38
Brand Estimate*
₹327.91
Estimated Savings:₹258.53 (79% saved)
Find a Kendra Near You
*Statutory price across 21,118 listed Kendras
Clinical InformationReport Error

Clinical Overview

Fluvoxamine Maleate is a selective serotonin reuptake inhibitor (SSRI) with notable affinity for sigma-1 receptors in the central nervous system, contributing to neuroprotective and anti-inflammatory effects. Indicated primarily for obsessive-compulsive disorder (OCD) and social anxiety disorder.

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 1124.Report inaccuracy

Usage Guidelines

Take orally with a glass of water, preferably at bedtime for single daily doses, with or without food. For divided doses, take morning and night as instructed. Taper gradually when stopping.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Nausea, vomiting, somnolence, insomnia, dizziness, dry mouth, asthenia, dyspepsia. Rare/Severe: Boxed warning: Suicidality; serotonin syndrome, seizures, and severe hyponatremia.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Boxed warning for suicidality in children/young adults. Potent inhibitor of CYP1A2 and CYP2C19; strongly increases levels of clozapine, theophylline, tizanidine, and warfarin. Contraindicated with ramelteon or MAOIs.

Schedule H (Prescription Required)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.